Biotechnology · Health Care
Adaptive Biotech revenue, results and funding
Adaptive Biotech filed revenue of $277M for 2025.
Data updated Nov 20, 2026 · Back to the company report
$277MRevenue, 2025
−$59.5MNet income, 2025
Results by year
| Year | Revenue | Net income | Total assets | LANG_CR_S_M_TAX_EXPENSE | LANG_CR_S_M_CAPEX | LANG_CR_S_M_SBC | LANG_CR_S_M_RND | LANG_CR_S_M_OPERATING_INCOME | LANG_CR_S_M_CASH | LANG_CR_S_M_DEBT |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | $277M | −$59.5M | $512.7M | $0 | $3M | $51.5M | $93.8M | −$57.1M | $70.5M | $126.6M |
| 2024 | $179M | −$159.5M | $539.4M | $0 | $3.7M | $53.6M | $103M | −$162.5M | $47.9M | $132.4M |
| 2023 | $170.3M | −$225.3M | $661.1M | $0 | $10.7M | $62.9M | $122.1M | −$227M | $65.1M | $130.7M |
| 2022 | $185.3M | −$200.2M | $856.6M | – | $16.3M | $55.5M | $141.8M | −$200.2M | $90M | $125.4M |
| 2021 | $154.3M | −$207.3M | $923.3M | – | $61.7M | $43.3M | $142.3M | −$209M | $139.1M | – |
| 2020 | $98.4M | −$146.2M | $1.1B | – | $18.8M | $24.8M | $116.1M | −$152.8M | $123.4M | – |
| 2019 | $85.1M | −$68.6M | $912.3M | – | $11.2M | $13.1M | $70.7M | −$78.4M | $96.6M | – |
| 2018 | $55.7M | −$46.4M | $332.7M | – | $6.3M | $11.1M | $39.2M | −$49.8M | $55M | – |
| 2017 | $38.4M | −$42.8M | – | – | $2.4M | $7M | $32M | −$44.5M | – | – |
Sources: SEC
How to cite
Adaptive Biotech, Financials. Alion, Nov 20, 2026. https://alion.io/company/adaptivebiotech/financials
